Navigation Links
If you don't want to fall ill this Christmas, then share a festive kiss but don't shake hands
Date:12/19/2007

We've all heard people say 'I won't kiss you, I've got a cold'. But a report just published warns that we may be far more at risk of passing on an infection by shaking someone's hand than in sharing a kiss.

A group of hygiene experts from the United States and the UK have published the first detailed report on hand hygiene in the home and community, rather than in hospital and healthcare settings. Their findings are published in the American Journal of Infection Control. They say that, if we want to avoid catching flu or tummy bugs, or protect ourselves and others from organisms such as MRSA, salmonella or C. difficile, then we have to start in our own homes, by paying greater attention to good hand hygiene. They also warn that, in the event of a flu pandemic, good hand hygiene will be the first line of defence during the early critical period before mass vaccination becomes available. This new report follows on from a study published last month in the British Medical Journal which indicated that physical barriers, such as regular handwashing and wearing masks, gloves and gowns may be more effective than drugs in preventing the spread of respiratory viruses such as influenza and SARS.

Good hygiene at home prevents organisms spreading from one family member to another. By reducing the number of carriers in the community, the likelihood of infections being carried into health care facilities by new patients and visitors is reduced. Good hygiene at home also means fewer infections, which means fewer patients demanding antibiotics from the GP, and fewer resistant strains developing and circulating in the community.

Cold and flu viruses can be spread via the hands so that family members become infected when they rub their nose or eyes. The report details how germs that cause stomach infections such as salmonella, campylobacter and norovirus can also circulate directly from person to person via our hands. If we put our fingers in our mouth
'/>"/>

Contact: Sally Bloomfield
sallyfbloomfield@aol.com
07-919-554-781
London School of Hygiene & Tropical Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. All eukaryotic kinases share 1 common set of substrates
2. How to share a bat
3. Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
4. Hungry microbes share out the carbon in the roots of plants
5. Humans and monkeys share Machiavellian intelligence
6. Scientists gather in New Zealand to share oceans secrets
7. Eat chocolate, drink wine, add fun to life: SLU geriatrician shares secrets of staying young

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...y of Pittsburgh team overcame a major hurdle plagu... that could lead to more efficient catalysts used ...xic. The researchers reported Nov. 29 in Nature M...ure stability in metallic nanoparticles, the vaunt...bility to extreme heat. , Gtz Veser, an associat...
(Date:11/30/2009)...ournal of Experimental Biology are pleased to ann...e la Recherche Scientifique (CNRS) in the Universi...ear,s JEB Outstanding Paper Prize. ,The prize is...ent and is intended to encourage young scientists,...and adds that ,we truly appreciate when authors su...
(Date:11/30/2009)...er early bird registration rates and register onli...010 at http://www.iofwco-ecceo10.org/ , WHAT:...ational Osteoporosis Foundation (IOF) and the Euro...Osteoporosis and Osteoarthritis (ESCEO). More than...cted to attend. The exciting scientific programme ...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Perrigo Company To Present at the Sidoti Emerging Growth Conference 6399 1How to execute dietary management in eating disorder patients 61699 1How to execute dietary management in eating disorder patients 61699 2TGen Drug Development establishes European footprint 10804 1TGen Drug Development establishes European footprint 10804 2
... identified a gene ?and the molecular function of ...ue to further understanding obesity and may point ..., The scientists found that the human protein know... activity may be an important pharmaceutical targe...conditions that range from obesity to the loss of ...
...a risk for gastrointestinal illness, most visitors...d prevent infection. In addition, some engage in b...on according to several studies being presented th...g Infectious Diseases. , Researchers from the CDC... of an outbreak of , E. coli O157:H7 associated ...
...ail of scents when they are attacked by certain pe...otton leaf worm. , Parasitic wasps use these plant...eir eggs on it, so that their offspring can feed o...es and the plant is relieved from its attacker. In... activated to attract the parasitic wasps. This ge...
Other Biology News:Rutgers researchers find fat gene 2Common practices at petting zoos put visitors at risk 2New possibilities to fight pests with biological means 2
(Date:11/30/2009)... international team of applied scientists from Har...nstrated compact, multibeam, and multi-wavelength ... spectrum (infrared). By contrast, typical lasers ...gth. The innovative multibeam lasers have potentia...ensing pollution monitoring, optical wireless, and...
(Date:11/30/2009)...wswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ...y that the company will be presenting at the 21st ...2009 at 12:30 pm local time at The New York Palace...he company,s business strategy, research and devel...o the live audio only presentation can be accessed...
(Date:11/30/2009)...S ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall/ --,...Board: CYXN; ,China Yongxin,Pharmaceuticals, or ,t...and,retailer of pharmaceuticals in Northeastern Ch...for distribution of medicines on the Essential Dru... formalized the nation,s Essential Drug,List which...
(Date:11/30/2009)...wire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (... class of platinum-based anti-tumor compounds, ter...umor potency and activity compared to currently av...ility to overcome cisplatin-resistance in cancer c...titled "Novel Bis-platinum Complexes Endowed with ...
Breaking Biology Technology:Scientists demonstrate multibeam, multi-functional lasers 2NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3
...AIN VIEW, Calif., March 12 Alexza,Pharmaceuticals...ll release,results for its fiscal year ended Decem...the close of the U.S. financial markets. The Compa...s the financial results and other,clinical develop...ay. A,replay of the call will be available for two...
...ded Agreement Accelerates Expected Timing of Final...le Powering of Interim and Final Results-, -Dendre...2008 at 11:00 AM ...daq: DNDN ) today announced that the U.S. Food an...ed Special Protocol Assessment (SPA) for the,Phase...
...nds PDE10 Collaboration with Amgen- -Com...ONTVALE, N.J., March 12 Memory,Pharmaceuticals Co...ealigned,its operations, reallocated its resources...its PDE10 collaboration with Amgen. The Company wi...o partnered programs, its,nicotinic alpha-7 recept...
Other Biology Technology:Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 2Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 2FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 2Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 3Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 5
Fingerprinting II Informatix, optional matrix types module from Bio-Rad
... Lines ,High Quality, Functionally-Validated, Ion ...for having a critical role in nerve and muscle fun..., CNS and the heart. Drugs that modulate ion chann...uch as neuropathic pain, cardiac arrhythmia, hyper...
...are derived from frozen embedded tissue blocks, wh...edures to ensure the highest quality. Tissues of e...tioned at a thickness of 7 microns and mounted on ...ter) in comparison to core sections made using Tis...
...ations or for use in an automated line. The StatMa...fold provides greater ease, speed, convenience, an...StatMatic II can be connected to a range of bottle...ne-handed operation -- in a matter of seconds.,T...
Biology Products: